National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Exenatide (Bydureon®) for the treatment of type II diabetes mellitus combined with Metformin, Sulphonylurea, Thiazolidinedione, Metform and SU and Metformn and TZD in adults who have not acheived glycaemic control on maximally tolerated doses of these oral therapies.

Rapid Review

Commenced Completed Outcome
31/05/2011 09/06/2011 Full Pharmacoeconomic Evaluation not Recommended